| Code | Description | Claims | Beneficiaries | Total Paid |
| J0178 |
Injection, aflibercept, 1 mg |
7,143 |
4,594 |
$3.91M |
| 67028 |
Intravitreal injection of a pharmacologic agent |
17,942 |
10,659 |
$688K |
| J2778 |
Injection, ranibizumab, 0.1 mg |
302 |
269 |
$199K |
| 92134 |
|
17,223 |
12,479 |
$112K |
| J9035 |
Injection, bevacizumab, 10 mg |
4,702 |
2,972 |
$80K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
709 |
484 |
$13K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
182 |
149 |
$10K |
| 92014 |
Ophthalmological services: medical examination and evaluation, comprehensive, established patient |
838 |
690 |
$6K |
| 92235 |
|
138 |
118 |
$4K |
| 92250 |
|
193 |
170 |
$2K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
36 |
18 |
$865.73 |
| 92012 |
Ophthalmological services: medical examination and evaluation, intermediate, established patient |
236 |
154 |
$602.03 |